CyberKnife; GTV median dose; Lung SBRT; Monte-Carlo re-prescription; Predictive nomogram; Humans; Linear Models; Lung/radiation effects; Monte Carlo Method; Multivariate Analysis; Organs at Risk; Radiation Dosage; Radiotherapy Planning, Computer-Assisted/methods; Algorithms; Radiosurgery/methods; Radiotherapy Dosage; Lung; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Biophysics; Radiology, Nuclear Medicine and Imaging; Physics and Astronomy (all); General Physics and Astronomy; General Medicine
Abstract :
[en] BACKGROUND AND PURPOSE: The use of Monte Carlo (MC) dose calculation algorithm for lung patients treated with stereotactic body radiotherapy (SBRT) can be challenging. Prescription in low density media and time-consuming optimization conducted CyberKnife centers to propose an equivalent path length (EPL)-to-MC re-prescription method based on GTV median dose. Unknown at the time of planning, GTV D50% practical application remains difficult. The current study aims at creating a re-prescription predictive model in order to limit conflicting dose value during EPL optimization.
MATERIAL AND METHODS: 129 patients planned with EPL algorithm were recalculated with MC. Relative GTV_D50% discrepancies were assessed and influencing parameters identified using wrapper feature selection. Based on best descriptive parameters, predictive nomogram was built from multivariate linear regression. EPL-to-MC OARs near max-dose discrepancies were reported.
RESULTS: The differences in GTV_D50% (median 10%, SD: 9%) between MC and EPL were significantly (p < .001) impacted by the lesion's surface-to-volume ratio and the average relative electronic density of the GTV and the GTV's 15 mm shell. Built upon those parameters, a nomogram (R2 = 0.79, SE = 4%) predicting the GTV_D50% discrepancies was created. Furthermore EPL-to-MC OAR dose tolerance limit showed a strong linear correlation with coefficient range [0.84-0.99].
CONCLUSION: Good prediction on the required re-prescription can be achieved prior planning using our nomogram. Based on strong linear correlation between EPL and MC for OARs near max-dose, further restriction on dose constraints during the EPL optimization can be warranted. This a priori knowledge eases the re-prescription process in limiting conflicting dose value.
Disciplines :
Physics
Author, co-author :
Dechambre, D; Liege University Hospital, Department of Radiation Oncology, Liège, Belgium. Electronic address: ddechambre@chu.ulg.ac.be
Janvary, L Z; Debrecen University Hospital, Department of Radiation Oncology, Debrecen, Hungary
Jansen, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
Berkovic, P; University of Leuven, Department of Oncology, Leuven, Belgium
MIEVIS, Carole ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
Baart, Véronique ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
CUCCHIARO, Séverine ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie
Coucke, Philippe ; Université de Liège - ULiège > Département des sciences cliniques > Radiothérapie
Gulyban, A; Liege University Hospital, Department of Radiation Oncology, Liège, Belgium
Language :
English
Title :
Prediction of GTV median dose differences eases Monte Carlo re-prescription in lung SBRT.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Chang, J.Y., Senan, S., Paul, M.A., Mehran, R.J., Louie, A.V., Groen, H.J.M., et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16 (2016), 630–637, 10.1016/S1470-2045(15)70168-3.Stereotactic.
Bezjak A. RTOG 0813: Seamless Phase I/Ii Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients. 2011.
Timmerman RD, Michalski J, Fowler J, Choy H, Johnstone D, Galvin JM, et al. Radiation therapy oncology group RTOG 0236 A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I / II Non-Small Cell Lung Cancer. 2004;6.
Harada, K., Katoh, N., Suzuki, R., Ito, Y.M., Shimizu, S., Onimaru, R., et al. Evaluation of the motion of lung tumors during stereotactic body radiation therapy (SBRT) with four-dimensional computed tomography (4DCT) using real-time tumor-tracking radiotherapy system (RTRT). Phys Medica 32 (2016), 305–311, 10.1016/j.ejmp.2015.10.093.
Janvary, Z.L., Jansen, N., Baart, V., Devillers, M., Dechambre, D., Lenaerts, E., et al. Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy. Radiol Oncol 51 (2017), 178–186, 10.1515/raon-2017-0015.
Search, H., Journals, C., Contact, A., Iopscience, M., Address IP. Collapsed cone and analytical anisotropic algorithm dose calculations compared to VMC ++ Monte Carlo simulations in clinical cases. J Phys Conf Ser, 21007, 2007, 10.1088/1742-6596/74/1/012007.
Kawrakow, I., Fippel, M., Investigation of variance reduction techniques for Monte Carlo photon dose calculation using XVMC. Phys Med Biol 45 (2000), 2163–2183, 10.1088/0031-9155/45/8/308.
Toutaoui, A., Ait chikh, S., Khelassi-Toutaoui, N., Hattali, B., Monte carlo photon beam modeling and commissioning for radiotherapy dose calculation algorithm. Phys Medica 30 (2014), 833–837, 10.1016/j.ejmp.2014.05.007.
Ma, C.-M., Mok, E., Kapur, A., Pawlicki, T., Findley, D., Brain, S., et al. Clinical implementation of a Monte Carlo treatment planning system. Med Phys 26 (1999), 2133–2143, 10.1118/1.598729.
van der Voort van Zyp, N.C., Hoogeman, M.S., van de Water, S., Levendag, P.C., van der Holt, B., Heijmen, B.J., et al. Clinical introduction of Monte Carlo treatment planning: a different prescription dose for non-small cell lung cancer according to tumor location and size. Radiother Oncol 96 (2010), 55–60, 10.1016/j.radonc.2010.04.009.
Bibault, J.E., Mirabel, X., Lacornerie, T., Tresch, E., Reynaert, N., Lartigau, E., Adapted prescription dose for monte carlo algorithm in lung SBRT: clinical outcome on 205 patients. PLoS One, 10, 2015, 10.1371/journal.pone.0133617.
Program C, Quantities F, Quality I, Ion-beam R. The International commission on radiation units and measurements. J ICRU 2010;10:NP.2-NP. doi: http://doi.org/10.1093/jicru/ndq001.
Lacornerie, T., Lisbona, A., Mirabel, X., Lartigau, E., Reynaert, N., GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms. Radiat Oncol, 9, 2014, 223, 10.1186/s13014-014-0223-5.
Timmerman, R.D., An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 18 (2008), 215–222, 10.1016/j.semradonc.2008.04.001.
Dechambre, D., Baart, V., Cucchiaro, S., Ernst, C., Jansen, N., Berkovic, P., et al. Commissioning Monte Carlo algorithm for robotic radiosurgery using cylindrical 3D-array with variable density inserts. Phys Med 33 (2017), 152–158, 10.1016/j.ejmp.2017.01.005.
Nalbantov, G., Kietselaer, B., Vandecasteele, K., Oberije, C., Berbee, M., Troost, E., et al. Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiother Oncol 109 (2013), 100–106, 10.1016/j.radonc.2013.08.035.
Kohavi, R., John, G.H., Wrappers for feature subset selection. Artif Intell 97 (1997), 273–324, 10.1016/S0004-3702(97)00043-X.
Schuring, D., Hurkmans, C.W., Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose. Radiat Oncol, 3, 2008, 21, 10.1186/1748-717X-3-21.
Rassiah-Szegedi, P., Salter, B.J., Fuller, C.D., Blough, M., Papanikolaou, N., Fuss, M., Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). Acta Oncol 45 (2006), 989–994, 10.1080/02841860600919225.
Berkovic, P., Gulyban, A., Nguyen, P.V., Dechambre, D., Martinive, P., Jansen, N., et al. Stereotactic robotic body radiotherapy for patients with unresectable hepatic oligorecurrence. Clin Colorectal Cancer, 2016, 10.1016/j.clcc.2017.03.006.
Berkovic, P., Gulyban, A., Swenen, L., Dechambre, D., Viet Nguyen, P., Jansen, N., et al. EP-1226: Stereotactic robotic body radiotherapy for patients with pulmonary oligometastases. Radiother Oncol 123 (2017), S661–S662, 10.1016/S0167-8140(17)31661-4.
Zhuang, T., Djemil, T., Qi, P., Magnelli, A., Stephans, K., Videtic, G., et al. Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy. J Appl Clin Med Phys, 14, 2013, 4011, 10.1120/jacmp.v14i2.4011.
Zhuang, T., Djemil, T., Qi, P., Magnelli, A., Stephans, K., Videtic, G., et al. Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy. J Appl Clin Med Phys 14 (2013), 38–51, 10.1120/jacmp.v14i2.4011.
Zheng, D., Zhu, X., Zhang, Q., Liang, X., Zhen, W., Lin, C., et al. Target dose conversion modeling from pencil beam (PB) to Monte Carlo (MC) for lung SBRT. Radiat Oncol, 11, 2016, 83, 10.1186/s13014-016-0661-3.
Liu, H., Zhuang, T., Stephans, K., Videtic, G., Raithel, S., Djemil, T., et al. Dose differences in intensity-modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT. J Appl Clin Med Phys, 16, 2015, 5514, 10.1120/JACMP.V16I6.5514.
Altunbas, C., Kavanagh, B., Dzingle, W., Stuhr, K., Gaspar, L., Miften, M., Dosimetric errors during treatment of centrally located lung tumors with stereotactic body radiation therapy: Monte Carlo evaluation of tissue inhomogeneity corrections. Med Dosim 38 (2013), 436–441, 10.1016/j.meddos.2013.06.002.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
